We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nordea Investment Management
276
Nordea Investment Management
Sweden
– -$705K -2,810 Closed
TI
277
Tidal Investments
Wisconsin
– -$684K -2,783 Closed
OPPTF
278
OPSEU Pension Plan Trust Fund
Ontario, Canada
– -$695K -2,740 Closed
AIM
279
Achmea Investment Management
Netherlands
– -$661K -2,692 Closed
MLICM
280
Metropolitan Life Insurance Company (MetLife)
New York
– -$652K -2,653 Closed
NB
281
Norinchukin Bank
Japan
– -$649K -2,643 Closed
GC
282
Guggenheim Capital
Illinois
– -$642K -2,615 Closed
JMPWA
283
JP Morgan Private Wealth Advisors
California
– -$634K -2,582 Closed
CGH
284
Crossmark Global Holdings
Texas
– -$631K -2,570 Closed
DIA
285
Dana Investment Advisors
Wisconsin
– -$621K -2,529 Closed
PL
286
Plancorp LLC
Missouri
– -$595K -2,422 Closed
NMERB
287
New Mexico Educational Retirement Board
New Mexico
– -$577K -2,350 Closed
SLAM
288
Swiss Life Asset Management
– -$575K -2,344 Closed
CIBC Private Wealth Group
289
CIBC Private Wealth Group
Georgia
– -$575K -2,339 Closed
VF
290
Virtu Financial
New York
– -$571K -2,325 Closed
Schroder Investment Management Group
291
Schroder Investment Management Group
United Kingdom
– -$569K -2,317 Closed
SG
292
Stonnington Group
California
– -$582K -2,300 Closed
GLA
293
Great Lakes Advisors
Illinois
– -$560K -2,279 Closed
LP
294
LMR Partners
United Kingdom
– -$535K -2,178 Closed
TSS
295
Two Sigma Securities
New York
– -$535K -2,177 Closed
BA
296
Bristlecone Advisors
Washington
– -$529K -2,153 Closed
SG Americas Securities
297
SG Americas Securities
New York
– -$523K -2,128 Closed
KAS
298
Kestra Advisory Services
Texas
– -$517K -2,106 Closed
Los Angeles Capital Management
299
Los Angeles Capital Management
California
– -$517K -2,104 Closed
QCM
300
Quantinno Capital Management
New York
– -$511K -2,081 Closed
10 11
12
13 14

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.